Physician
Obstetrics & Gynecology
Dr. Earl A. Surwit, MD
|
|
Give Review
Earl Surwit works in the field of Obstetrics & Gynecology. He went to Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49 in research and 84 in primary care medicine Earl A. Surwit, MD is also a published MD. He has 99 publication published. The most recent publication is: Laparoscopic staging of endometrial cancer: the learning experience. Earl Surwit accepts Medicare payments and is listed with Medicare.gov.
Publications
- Neuromodulation of the pudendal, hypogastric, and tibial nerves with pelvic floor muscle rehabilitation in the treatment of urinary urge incontinence.
- Treatment of locally advanced cancer of the cervix with transperineal interstitial irradiation. Report on 106 cases.
- Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.
- Comparative exposure ratios: a non-parametric, multifactor technique for case-control studies.
- Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group study.
- Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group study.
- Amsacrine (m-AMSA) in squamous cell carcinoma of the Uterine cervix: a Southwest Oncology Group study.
- Radical hysterectomy with or without preoperative radium for stage IB squamous cell carcinoma of the cervix.
- Invasive carcinoma of the cervix treated primarily with radiation therapy: University of Arizona experience.
- Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
- Abdominal-wall tumor implantation after laparoscopy for malignant conditions.
- Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
- Laparoscopic surgical staging of ovarian cancer.
- Stage II carcinoma of the endometrium.
- Stage I cancer of the endometrium.
- Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.
- Adjunctive radiation therapy in the management of stage I cancer of the endometrium.
- Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients.
- The management of carcinoma of the ovary.
- Malignant pelvic lymphoma.
- Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions.
- In vitro retinoid binding and release from a collagen sponge material in a simulated intravaginal environment.
- Treatment of advanced cancer of the cervix with transperineal interstitial irradiation.
- Radical hysterectomy with preoperative intracavitary therapy for stage IB squamous cell carcinoma of the cervix.
- Stage II carcinoma of the endometrium. An analysis of treatment.
- Choriocarcinoma following term pregnancy.
- A new combination chemotherapy for resistant trophoblastic disease.
- Adenoid cystic carcinoma of the Cervix. Report of 9 cases and a reappraisal.
- Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen.
- Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
- Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide).
- Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture.
- Sex assignment in gestational trophoblastic neoplasia.
- The management of poor prognosis trophoblastic disease.
- Recurrent gestational trophoblastic disease.
- Management of high-risk metastatic disease.
- Late recurrences of gestational trophoblastic neoplasia.
- Treatment of metastatic trophoblastic disease with poor prognosis.
- Activity of isotretinoin against squamous cell cancers and preneoplastic lesions.
- Poor-prognosis gestational trophoblastic disease: an update.
- Multiagent chemotherapy in relapsing ovarian cancer.
- Interstitial thermoradiotherapy in recurrent gynecologic malignancies.
- Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.
- Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix.
- In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.
- Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers.
- Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study.
- Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia.
- A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy.
- An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients.
- Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study.
- Tamoxifen therapy in recurrent epithelial ovarian carcinoma.
- Interstitial parametrial implants in carcinoma of the cervix stage II-B.
- Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.
- Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.
- Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgery.
- Phase II trial of mitomycin C plus 5-FU in the treatment of drug-refractory ovarian cancer.
- Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and nonhormonal activators.
- Meigs syndrome and elevated CA 125.
- Management of high-risk gestational trophoblastic disease.
- The role of serum and tissue pharmacology studies in the design and interpretation of chemoprevention trials.
- Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: a Southwest Oncology Group ...
- Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: a Southwest Oncology Group Study.
- A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
- Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study.
- Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group...
- A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the Uterine cervix: a Southwest Oncology Group trial.
- A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the Uterine cervix: a Southwest Oncology Group study.
- Development of a contingency recruitment plan for a phase III chemoprevention trial of cervical dysplasia.
- Carboplatin therapy in advanced endometrial cancer.
- High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
- Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
- Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.
- Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer.
- Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III ran...
- Evaluation of amonafide in cervical cancer, phase II. A SWOG study.
- Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer.
- Office laparoscopy and biopsy for evaluation of patients with intraperitoneal carcinomatosis using a new optical catheter.
- The role of laparoscopic lymphadenectomy in the management of cervical carcinoma.
- Laparoscopic para-aortic lymph node biopsy for diagnosis of a non-Hodgkin's lymphoma.
- Laparoscopic sacral colpopexy: a proposed technique.
- Laparoscopic surgical staging of stage I primary squamous cell carcinoma of the vagina.
- Laparoscopic staging of endometrial cancer: the learning experience.
- Role of operative laparoscopy in gynecologic oncology.
- Transabdominal cerclage: a laparoscopic approach.
- Laparoscopic hysterectomy for persistent gestational trophoblastic neoplasia.
- Laparoscopic management of suspicious adnexal masses.
- The role of laparoscopy in gynecologic oncology.
- Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
- Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stag...
- Laparoscopic trocar-assisted colpotomy.
- Laparoscopic para-aortic lymphadenectomy in gynecologic malignancies.
- Laparoscopy using the left upper quadrant as the primary trocar site.
- Current status of operative laparoscopy in gynecologic oncology.
- Laparoscopic staging of Hodgkin's lymphoma.
- Laparoscopically assisted surgical staging (LASS) of endometrial cancer.
- Laparoscopic staging of the patient with incompletely staged early adenocarcinoma of the endometrium.
- A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia.
Schools
Georgetown University School Of Medicine
University Of North Carolina Hospital
Duke University Medical Center
Procedures Preformed
- Gynecologic Cancer Screening
Conditions Treated
- Atrophic Vaginitis
- Hyperlipidemia
- Sexually Transmitted Diseases (STDs)
- Uterine Prolapse
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Education
-
University of North Carolina Hospitals -
Georgetown University School of Medicine
Drug Facts
| NPI NUMBER | 1760411854 | |
| NPPES Provider LastName | SURWIT | |
| NPPES Provider FirstName | EARL | |
| NPPES Provider ZIPCode | 857125833 | |
| NPPES Provider State | AZ | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 106.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760411854 |
| Last Name Of The Provider | SURWIT |
| First Name Of The Provider | EARL |
| View All |
Similar Doctors
|
|
Dr. Marvin L. Bates, MD |
|
Dr. Vicky E. Sherman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janiel M. Cragun, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scot M. Hutchison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth D. Hatch, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Linda S. Turner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank J. Laudonio Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kami M. Dixon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph Buscema, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Catherine M. Westerband, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Candice N. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alton V. Hallum III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela A. Morford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica Moreno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynn Coppola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Setsuko Chambers, MD
This Doctor is OpenDoctor Recommended.
|